medRxiv

Combining measures improves prediction of Alzheimer’s markers

Combining two kinds of language analysis with thinking-test scores outperformed each approach alone across all eight tasks predicting genetic risk or brain protein buildup.

A brain cross-section with dense and sparse protein deposits is surrounded by small upright people and speech bubbles containing overlapping shapes.

Our read

Biomarkers
Studied:
Preprint: study of Hebrew- and English-speaking participants, against each individual prediction approach
What changed:
Combining language measures and thinking-test scores improved prediction of genetic risk and brain amyloid across all eight tasks versus individual approaches
The catch:
Genetic risk and brain amyloid are stand-ins for Alzheimer’s diagnosis

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Hebrew- and English-speaking participants in two cohorts of 134 and 1,541 people provided picture descriptions for an observational prediction study. Researchers compared large language models’ numerical representations of language with theory-based language measures and thinking-test scores. They predicted carriage of APOE4, a genetic variant associated with Alzheimer’s risk, and levels of amyloid-beta, a protein that can build up in the brain.

Language-model approaches scored highest among individual approaches in five of eight tasks involving the variant or overall brain amyloid. Combining all three approaches, with a positive result from any one counting as positive, outperformed every approach alone across all eight tasks. The combination also outperformed every individual approach in 21 of 24 tasks involving amyloid in specific brain regions.

Why it matters

Spontaneous language may offer a scalable, noninvasive route to identifying biological signs of preclinical Alzheimer’s disease. The authors support further investigation of its potential for early screening.

Caveats

Predicting genetic risk and brain amyloid does not by itself establish accuracy for diagnosing Alzheimer’s disease. This preprint has not been peer-reviewed.

Comments

Be the first to comment.